Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes

Blood

Volumn 101, Issue 5, 2003, Pages 1874-1881

  Baumgartner, Martin ^b   Angelisová, Pavla ^b   Setterblad, Niclas ^b   Mooney, Nuala ^b   Werling, Dirk ^b   Horejsí, Václav ^b   Langsley, Gordon ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE CSK; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CATTLE; CELL MEMBRANE; CELL TRANSFORMATION; COMPLEX FORMATION; CONTROLLED STUDY; GLYCOLIPID ENRICHED MICRODOMAIN; LIPID RAFT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PARASITE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THEILERIA;

EID: 0037369262     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0456     Document Type: Article

References (55)

1. Dobbelaere DAE, Coquerelle TM, Roditi IJ, Eichhorn M, Williams RO. Theileria parva infection induces autocrine growth of bovine lymphocytes. Proc Natl Acad Sci U S A. 1988;85:4730-4734.
2. Fell AH, Preston PM, Ansell JD Establishment of Theileria-infected bovine cell lines in scid mice. Parasite Immunol. 1990;12:335-339.
3. Irvin AD, Brown CG, Kanhai GK, Kimber CD, Crawford JG. Response of whole-body irradiated mice to inoculation of Theileria parva-infected bovine lymphoid cells. J Comp Pathol. 1974;84:291-300.
4. Irvin AD, Brown CG, Kanhai GK, Stagg DA. Comparative growth of bovine lymphosarcoma cells and lymphoid cells infected with Theileria parva in athymic (nude) mice. Nature. 1975;255:713-714.
5. Eichhorn M, Dobbelaere DAE. Induction of signal transduction pathways in lymphocytes infected by Theileria parva. Parasitol Today. 1994;10:469-472.
6. Chaussepied M, Langsley G. Theileria transformation of bovine leukocytes: a parasite model for the study of lymphoproliferation. Res Immunol. 1996;147:127-138.
7. Galley Y, Hagens G, Glaser I, Davis W, Eichhorn M, Dobbelaere D. Jun NH2-terminal kinase is constitutively activated in T-cells transformed by the intracellular parasite Theileria parva. Proc Natl Acad Sci U S A. 1997;94:5119-5124.
8. Chaussepied M, Lallemand D, Moreau M-F, Adamson R, Hall R, Langsley G. Upregulation of Jun and Fos family members and permanent JNK activity lead to constitutive AP-1 activation in Theileria-transformed leukocytes. Mol Biochem Parasitol. 1998;94:215-226.
9. Botteron C, Dobbelaere D. AP-1 and ATF-2 are constitutiveley activated via the JNK pathway in Theileria parva-transformed cells. Biochem Biophys Res Commun. 1998;246:418-421.
10. Hudson AT, Randall AW, Fry M, et al. Novel antimalarial hydroxynaphtoquinones with broad spectrum anti-protozoal activity. Parasitology. 1985;90:45-55.
11. Dobbelaere D, Heussler V. Transformation of leukocytes by Theileria parva and T. annulata. Annu Rev Microbiol. 1999;53:1-42.
12. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
13. Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 1997;385:595-601.
14. Burkhardt AL, Brunswick M, Bolen JB, Mond JJ. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci U S A. 1991;88:7410-7414.
15. Parsons JT, Parsons SJ. Src family tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol. 1997;9:187-192.
16. Hallek M, Neumann C, Schäffer M, et al. Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. Exp Hematol. 1997;25:1367-1377.
17. Ma Y-C, Huang J, Ali S, Lowry W, Huang XY. Src tyrosine kinase is a novel direct effector of G proteins. Cell. 2000;102:635-646.
18. Roach T, Slater S, Koval M, et al. CD45 regulates Src family kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol. 1997;7:408-417.
19. Brown MT, Cooper JA. Regulation, substrates and function of src. Biochim Biophys Acta. 1996;1287:121-149.
20. Robbins SM, Quintrell NA, Bishop JM. Myristoylation and differential palmitoylation of the Hck protein-tyrosine kinases govern their attachment to membranes and association with calveolae. Mol Cell Biol. 1995;15:3507-3515.
21. Dorahy DJ, Burns GF. Active Lyn protein tyrosine kinase is selectively enriched within membrane microdomains of resting platelets. Biochem J. 1998;333:373-379.
22. Moarefi I, LaFevre-Bernt M, Sicher F, et al. Activation of the Src-family kinase Hck by SH3 domain displacement. Nature. 1997;385:650-653.
23. Pellicean P, Stowell KR, Miller WT. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain-binding sites. J Biol Chem. 1998;273:15325-15328.
24. c-src. Nature. 1991;349:172-175.
25. c-src: implications for regulation. Science. 1986;231:1431-1434.
26. Okada M, Nakagawa H. A protein tyrosine kinase involved in regulation of pp60c-src function. J Biol Chem. 1989;264:20886-20893.
27. c-src. Nature. 1991;351:69-72.
28. Shalloway D, Taylor SJ. Src: more than the sum of its parts. Trends Cell Biol. 1997;7:215-217.
29. c-src by overexpression of a protein tyrosine phosphatase. Nature. 1992;359:336-338.
30. Zheng X-M, Resnick RJ, Shalloway D. A phosphotyrosine displacement mechanism for activation of Src by PTPα. EMBO J. 2000;19:964-978.
31. lck at Tyr-505 and down regulates its catalytic activity. EMBO J. 1992;11:2919-2924.
32. Brdicka T, Pavlistová D, Leo A, et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med. 2000;191:1591-1604.
33. Kawabuchi M, Satomi Y, Takao T, et al. Transmembrane phosphoprotein Cbp regulates activities of Src family tyrosine kinases. Nature. 2000;404:999-1003.
34. Takeuchi S, Takayama Y, Ogawa A, Tamura K, Okada M. Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk. J Biol Chem. 2000;22:183-186.
35. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513-609.
36. Fich C, Klauenberg U, Fleischer B, Bröker BM. Modulation of enzymatic activity of Src-family kinases in bovine T cells transformed by Theileria parva. Parasitology. 1998;117:107-115.
37. Eichhorn M, Dobbelaere DA. Partial inhibition of Theileria parva-infected T-cell proliferation by antisense IL2Rα-chain RNA expression. Res Immunol. 1995;146:89-99.
38. McKeever DJ, Nyanjui JK, Ballingall KT. In vitro infection with Theileria parva is associated with IL10 expression in all bovine lymphocyte lineages. Parasite Immunol. 1997;19:319-324.
39. Baumgartner M, Chaussepied M, Moreau M-F, et al. Constitutive PI3-K activity is essential for proliferation, but not survival of Theileria parva-transformed B cells. Cell Microbiol. 2000;4:329-339.
40. Dobbelaere DAE, Roditi IJ, Coquerelle TM, Kelke C, Eichhorn M, Williams RO. Lymphocytes infected with Theileria parva require both cell-cell contact and growth factor to proliferate. Eur J Immunol. 1991;21:89-95.
41. Barone MV, Courtneidge SA. Myc but not Fos rescue of PDGF signalling block by kinase-inactive Src. Nature. 1995;378:509-512.
42. 2 for fibroblast cell division. Science. 1995;269:1567-1569.
43. 1 phases of the cell cycle. Cell Growth Differ. 1993;4:671-678.
44. Penuel E, Martin GS. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways. Mol Biol Cell. 1999;10:1693-1703.
45. Dobbelaere DAE, Prospero TD, Roditi IJ, et al. I. Expression of the Tac component of bovine interleukin-2 receptor in different leukocyte populations infected with Theileria parva or Theileria annulata. Infect Immun. 1990;58:3847-3855.
46. Moreau M-F, Thibaut J-L, Ben Miled L, et al. Theileria annulata and CD5-positive macrophages and B1 cells. Infect Immun. 1999;67:6678-6682.
47. Scholz G, Cartledge K, Dunn AR. Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cbl and phosphatidylinositol 3-kinase. J Biol Chem. 2000;275:14615-14623.
48. Jin YJ, Albers MW, Lane WS, Bierer BE, Schreiber SL, Burakoff SJ. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13. Proc Natl Acad Sci U S A. 1991;88:6677-6681.
49. Cerny J, Stockinger H, Horejsi V. Noncovalent associations of T lymphocyte surface proteins. Eur J Immunol. 1996;26:2335-2343.
50. Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. J Biol Chem. 1993;268:23460-23468.
51. Pleiman CM, Hertz WM, Cambier JC. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science. 1994;263:1609-1612.
52. Reif K, Lucas S, Cantrell D. A negative role for phosphoinositide 3-kinase in T-cell antigen receptor function. Curr Biol. 1997;7:285-293.
53. Torgersen KM, Vang T, Abrahamsen H, et al. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src (Csk) from lipid rafts. J Biol Chem. 2001;276:29313-29318.
54. Itoh K, Sakakibara M, Yamasaki S, et al. Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J Immunol. 2002;168:541-544.
55. Brdickova N, Brdicka T, Andera L, et al. Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett. 2001;507:133-136.